Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$812,416
+$367,694 QoQ
Shares Held
173,965
+2.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 147 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Derivatives in CCCC
reported options exposure · as of Dec 31, 2024CallValue
$720,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. CCCC ranks #119 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CCCC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $812,416 | 173,965 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $444,722 | 169,096 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,029,116 | 9,439,328 | Shares | Defined | 2026-02-17 | |
| 2025-10-17 | $53,674,923 | 22,647,647 | Shares | Sole | 2025-10-20 | |
| 2025-03-31 | $378,968 | 236,855 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $707,277 | 196,466 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $720,000 | 200,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $6,850,533 | 1,201,848 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,287,039 | 278,580 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $7,405,876 | 906,472 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,081,678 | 1,961,359 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,799 | 16,021 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,031 | 6,557 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $74,521 | 23,733 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $12,224,322 | 503,888 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $8,936,000 | 200,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,266,304 | 165,600 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||